Albert Friedberg - Mar 28, 2024 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Director, 10%+ Owner
Signature
/s/ Maurice Zauderer, Attorney-in-Fact for Albert Friedberg
Stock symbol
VCNX
Transactions as of
Mar 28, 2024
Transactions value $
$1,599,998
Form type
4
Date filed
4/1/2024, 08:53 PM
Previous filing
Feb 9, 2024
Next filing
Apr 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCNX Common Stock Award $800K +103K +22.51% $7.77 560K Mar 28, 2024 By FCMI Parent Co. F3
holding VCNX Common Stock 2.09K Mar 28, 2024 Direct
holding VCNX Common Stock 180 Mar 28, 2024 By Pan Atlantic Holdings Ltd. F1
holding VCNX Common Stock 16.7K Mar 28, 2024 By Friedberg Global-Macro Hedge Fund Ltd. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Warrant (Right to Buy) Award $800K +103K $7.77 103K Mar 28, 2024 Common Stock 103K $7.64 By FCMI Parent Co. F3
holding VCNX Warrant (Right to Buy) 118K Mar 28, 2024 Common Stock 118K $14.00 By FCMI Parent Co. F3
holding VCNX Warrant (Right to Buy) 214K Mar 28, 2024 Common Stock 214K $14.00 By FCMI Parent Co. F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Friedberg is the majority owner of Pan Atlantic Holdings Ltd. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2 Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F3 Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Remarks:

On February 19, 2024, Vaccinex, Inc. effected a 1-for-14 reverse stock split (the "Reverse Stock Split"). The figures in this Form 4 reflect the Reverse Stock Split.